alpha-Amylases

Preferred Label : alpha-Amylases;

MeSH definition : Enzymes that catalyze the endohydrolysis of 1,4-alpha-glycosidic linkages in STARCH; GLYCOGEN; and related POLYSACCHARIDES and OLIGOSACCHARIDES containing 3 or more 1,4-alpha-linked D-glucose units.;

MeSH synonym : alpha-Amylase; alpha-1,4-d-glucanglucanohydrolase; alpha amylase; alpha 1,4 d glucanglucanohydrolase; alpha amylases;

CISMeF synonym : alpha amylase 2; alpha-amylase 2; bayer brand of alpha-Amylase; leurquin brand of alpha-Amylase; sanofi synthelabo brand of alpha-Amylase;

DeCS synonym : M gamylase;

MeSH hyponym : Taka-Amylase A; maxilase; mégamylase; Alpha-Amylase bayer; Taka Amylase A; TakaAmylase A; Alpha Amylase Bayer; AlphaAmylase Bayer;

MeSH CAS label : 1,4-alpha-D-Glucan glucanohydrolase;

MeSH Related Number : 9000-90-2 (CAS RN);

Registry Number MeSH : EC 3.2.1.1;

Wikipedia link : https://en.wikipedia.org/wiki/Alpha-amylase;

Codes EINECS : 232-565-6;

Is substance : O;

medicament (CISMeF) : O;

UNII : EC 3.2.1.1;

Details

Origin ID

D000516;

UMLS CUI

C0002245;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Alpha amylase [ICD-11 Extension code]
- Alpha amylase [ICHI extension code]
- Alpha-Amylase [NCIt concept]
- Alpha-amylase (substance) [SNOMED CT concept]
- alpha-amylase [SNOMED Notion]
- alpha-amylase [International Nonproprietary Name]
Exact mapping(s) to DCI
- alpha-amylase [International Nonproprietary Name]
Indexing information
- 24,25,26,27-tetranor-apotirucalla-(apoeupha)-1-senecioyloxy-3,7-dihydroxy-14,20,22-trien-21,23-epoxy [MeSH Supplementary Concept]
- 3,5-dihydroxypiperidine-4-yl O-glucopyranosyl-1-4-glucopyranoside [MeSH Supplementary Concept]
- 3-ketobutylidene 2-chloro-4-nitrophenylmaltopentaoside [MeSH Supplementary Concept]
- 4(2)-O-galactosyl maltobionolactone [MeSH Supplementary Concept]
- 4(3)-O-galactosyl maltotrionolactone [MeSH Supplementary Concept]
- 6(3)-deoxymaltotriose [MeSH Supplementary Concept]
- 8-benzyl-7-hydroxy-4-methyl-2H-chromen-2-one [MeSH Supplementary Concept]
- 8-benzyl-7-hydroxy-4-phenyl-2H-chromen-2-one [MeSH Supplementary Concept]
- AI 3688 [MeSH Supplementary Concept]
- AI 409 [MeSH Supplementary Concept]
- CMa protein, barley [MeSH Supplementary Concept]
- CMd protein, hordeum vulgare [MeSH Supplementary Concept]
- HAIM I protein, streptomyces griseosporeus [MeSH Supplementary Concept]
- IAM1 protein, hordeum vulgare [MeSH Supplementary Concept]
- NS 504 [MeSH Supplementary Concept]
- RBI protein, eleusine coracana [MeSH Supplementary Concept]
- T-76 protein, streptomyces nitrosporeus [MeSH Supplementary Concept]
- WDAI-3 protein, triticum aestivum [MeSH Supplementary Concept]
- WMAI-1 [MeSH Supplementary Concept]
- Z 2685 [MeSH Supplementary Concept]
- acarviosinyl-isomaltosyl-spiro-thiohydantoin [MeSH Supplementary Concept]
- acarviostatin III0(-1) [MeSH Supplementary Concept]
- acarviostatin III23 [MeSH Supplementary Concept]
- alpha-amylase inhibitor, phaseolus vulgaris [MeSH Supplementary Concept]
- alphaAI protein 1, phaseolus coccineus [MeSH Supplementary Concept]
- cimicifugic acid [MeSH Supplementary Concept]
- fukinolic acid [MeSH Supplementary Concept]
- gibbestatin B [MeSH Supplementary Concept]
- gnetin C [MeSH Supplementary Concept]
- hexahydro-3,5,6-trihydroxy-1H-azepine-4-yl O-glucopyranosyl-1-4-glucopyranoside [MeSH Supplementary Concept]
- methyl-4,4'-dithiomaltotrioside [MeSH Supplementary Concept]
- probable amylase-protease inhibitor-B, oryza sativa [MeSH Supplementary Concept]
- ro 09-0766 [MeSH Supplementary Concept]
- ro 09-0767 [MeSH Supplementary Concept]
- ro 09-0768 [MeSH Supplementary Concept]
- scirpusin B [MeSH Supplementary Concept]
- substance X-2, strep fradiae [MeSH Supplementary Concept]
- subtilisin inhibitor p20, oryza sativa [MeSH Supplementary Concept]
- tendamistate [MeSH Supplementary Concept]
Record concept(s)
- Alpha-Amylase bayer [MeSH concept]
- Taka-Amylase A [MeSH concept]
- alpha-Amylases [MeSH concept]
- maxilase [MeSH concept]
- mégamylase [MeSH concept]
Related MeSH Supplementary Concept(s)
- AAH3 protein, S pombe [MeSH Supplementary Concept]
- AMY1.2 protein, hordeum vulgare [MeSH Supplementary Concept]
- BE1 protein, arabidopsis [MeSH Supplementary Concept]
- BiLA protein, Bifidobacterium longum [MeSH Supplementary Concept]
- alpha-amylase carboxy terminal propeptide, pseudoalteromonas haloplanktis [MeSH Supplementary Concept]
- alpha-amylase, bacillus licheniformis [MeSH Supplementary Concept]
- amyl-1-18 octadecapeptide [MeSH Supplementary Concept]
- dermatophagoides pteronyssinus antigen p 4 [MeSH Supplementary Concept]
- glycosylated alpha-amylase [MeSH Supplementary Concept]
- termamyl [MeSH Supplementary Concept]
- trehalosyl dextrin-forming enzyme, sulfolobus solfataricus [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing alpha-amylase (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients